Yubo International Biotech LTD 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OQB
10-K: Yubo International Biotech Limited Reports Form 10-K Filing for Fiscal Year Ended December 31, 2024
Yubo International Biotech Limited files its Form 10-K, reporting financial results for the fiscal year ended December 31, 2024, highlighting a net loss and discussing risks associated with its VIE structure and operations in China.
OQB
Yubo International Biotech Limited's 2023 annual report details increased revenue driven by new health management services, alongside ongoing development of its endometrial stem cell bank.